Scientists Find Ocean Compound That Kills Brain Amoeba Fast

Scientists at UC San Diego just discovered a powerful new weapon against one of nature's deadliest parasites, and it comes from an unexpected ally: ocean bacteria.

The brain-eating amoeba, Naegleria fowleri, causes a rare infection called PAM that kills more than 97% of people who contract it. When the amoeba enters through the nose while swimming in warm freshwater, it travels to the brain where it destroys tissue and causes massive inflammation, usually proving fatal within days.

Current treatments take 16 hours to reach full strength and require such high doses that they harm human cells along with the amoeba. That's why researchers have been desperately searching for better options.

Enter rutamycin B, a compound isolated from marine bacteria by the UC San Diego team. In laboratory tests, this ocean-derived molecule killed five different strains of the amoeba in just four hours, a quarter of the time needed by today's primary treatment.

The compound works by blocking an enzyme the amoeba needs to produce energy. At low doses, rutamycin B proved 200 to 300 times more toxic to the parasite than to human cells, making it far safer for patients.

Even better, when researchers combined rutamycin B with the current treatment, they needed only 3% to 10% as much of the compound to achieve the same results. This synergy could mean gentler, more effective treatments for patients fighting for their lives.

"By identifying a compound that is both faster and more selective, we are moving closer to a treatment that can stop the infection before it causes irreversible damage," said study author Anjan Debnath, co-director of UC San Diego's Center for Discovery and Innovation in Parasitic Diseases.

While PAM remains incredibly rare with only 150 U.S. cases ever recorded, incidents are increasing globally and spreading northward in America. Studies show the amoeba thrives in popular recreational spots like hot springs at national parks, making effective treatments increasingly important.

The Bright Side

The discovery represents more than just hope for PAM patients. It highlights how Earth's oceans contain vast libraries of undiscovered medicines waiting to help humanity.

"The ocean contains a diverse library of chemicals, and we've only just scratched its surface," said co-author William Fenical, a distinguished professor emeritus at UC San Diego's Scripps Institution of Oceanography. "These results are a powerful reminder that the solutions to some of our most challenging medical problems may be hiding in unexpected places."

The research team still has work ahead, including animal testing and studying how well rutamycin B crosses the blood-brain barrier. But the initial results, published this week in the journal Marine Drugs, offer genuine hope for transforming a nearly always fatal diagnosis into a survivable one.

Sometimes the cure for our toughest challenges comes from the last place we'd expect to look.